S. Zambon et al., POLYUNSATURATED N-3 FATTY-ACIDS AND LIPOPROTEIN PHYSICAL-PROPERTIES IN PRIMARY HYPERTRIGLYCERIDEMIA, NMCD. Nutrition Metabolism and Cardiovascular Diseases, 4(4), 1994, pp. 183-187
The effects of n-3 polyunsaturated fatty acids on lipoprotein levels,
low-density lipoprotein (LDL) and high-density lipoprotein (HDL) size,
and plasma phospholipid fatty acids were examined in 17 hypertriglyce
ridemic patients. Plasma triglycerides levels fell by 31%, and both ch
olesterol and triglycerides in the very low-density lipoprotein fracti
on were reduced after 8 weeks of n-3 fatty acid supplementation (2.5 g
/day). LDL cholesterol tended to rise while no variations were observe
d in HDL cholesterol and lipoprotein(a) levels. Apolipoprotein A-II an
d C-III concentrations were significantly reduced by n-3 fatty acids.
LDL size (measured by gradient gel electrophoresis) was smaller than n
ormal and remained unmodified by n-3 fatty acid supplementation. Large
HDL, but not small HDL, cholesterol levels increased significantly. B
oth with and without n-3 fatty acid supplementation, LDL size was not
related to n-3, oleic, and linoleic fatty acid content in plasma phosp
holipids, but was always related to plasma triglyceride levels. n-3 fa
tty acids reduce triglycerides in humans without affecting LDL size de
spite significant changes in phospholipid fatty acid composition,